Notu Kiran, Kt Jayakumar, Rajesh Lenin Raji, G Nikhil Kumar, Kumar J S
General Medicine, Sri Ramaswamy Memorial (SRM) Medical College Hospital and Research Centre, Kattankulathur, IND.
Medical Research, Sri Ramaswamy Memorial (SRM) Medical College Hospital and Research Centre, Kattankulathur, IND.
Cureus. 2024 Aug 19;16(8):e67174. doi: 10.7759/cureus.67174. eCollection 2024 Aug.
Diabetic foot ulcers (DFUs) are a common complication of diabetes that affects patients' quality and prognosis of life. The study aims to assess the correlation between fibrinogen and glycated hemoglobin (HbA1c) in DFUs at the first and sixth months and to compare fibrinogen levels with Wagner classification in DFU patients.
This observational study was conducted at SRM Medical College Hospital and Research Centre from January 2021 to July 2022. Fifty diabetes patients with DFUs were selected, and informed consent was obtained before the study started. Blood samples were collected from all the participants for HbA1C, serum fibrinogen, hemoglobin, and white blood cells. In this study, data were entered into MS Excel (Microsoft Corporation, Redmond, WA) and analyzed using SPSS version 24 (IBM Corp., Armonk, NY). ANOVA and Pearson's correlation were used to examine the relationships between serum fibrinogen levels and clinical parameters.
Among 50 patients, the females were 16 (32%), and the males were 34 (68%). Most patients (34%) were in the 56-60 age group. Twenty patients had diabetes for 10 years, and 24 were diabetic for 11-15 years. The ankle-brachial index (ABI score) was mild in 14 patients (28%), moderate in 28 patients (56%), and normal in eight patients (16%). There is a significant difference in comparison between the Wagner classification and ABI. A significant difference was observed in fibrinogen at the first and sixth months between HbA1c first, third, and sixth months. Significant differences were also observed in fibrinogen and ABI in the first and sixth months.
Key findings include significant differences between fibrinogen and HbA1c levels (p < 0.0001) and a strong association between fibrinogen levels and ABI scores (p < 0.0001), underscoring fibrinogen's potential as an early marker for glycemic control and peripheral arterial disease in DFU patients. We concluded that simple fibrinogen estimation helps predict glycemic control in diabetic patients with DFUs.
糖尿病足溃疡(DFUs)是糖尿病常见的并发症,会影响患者的生活质量和预后。本研究旨在评估糖尿病足溃疡患者在第1个月和第6个月时纤维蛋白原与糖化血红蛋白(HbA1c)之间的相关性,并比较糖尿病足溃疡患者的纤维蛋白原水平与瓦格纳分级。
本观察性研究于2021年1月至2022年7月在SRM医学院医院及研究中心进行。选取50例糖尿病足溃疡患者,在研究开始前获得知情同意。采集所有参与者的血液样本,检测HbA1C、血清纤维蛋白原、血红蛋白和白细胞。在本研究中,数据录入MS Excel(微软公司,华盛顿州雷德蒙德),并使用SPSS 24版(IBM公司,纽约州阿蒙克)进行分析。采用方差分析和皮尔逊相关性分析来检验血清纤维蛋白原水平与临床参数之间的关系。
50例患者中,女性16例(32%),男性34例(68%)。大多数患者(34%)年龄在56 - 60岁组。20例患者患糖尿病10年,24例糖尿病病程为11 - 15年。14例患者(28%)踝肱指数(ABI评分)为轻度,28例患者(56%)为中度,8例患者(16%)正常。瓦格纳分级与ABI之间存在显著差异。在HbA1c第1个月、第3个月和第6个月时,第1个月和第6个月的纤维蛋白原存在显著差异。在第1个月和第6个月时,纤维蛋白原与ABI也存在显著差异。
主要发现包括纤维蛋白原与HbA1c水平之间存在显著差异(p < 0.0001),以及纤维蛋白原水平与ABI评分之间存在强关联(p < 0.0001),这突出了纤维蛋白原作为糖尿病足溃疡患者血糖控制和外周动脉疾病早期标志物的潜力。我们得出结论,简单的纤维蛋白原检测有助于预测糖尿病足溃疡患者的血糖控制情况。